Business
Why Lexicon Pharmaceuticals Stock Doubled and Then Some on Thursday – Motley Fool
The FDA delivered a powerful shot of good news to the company.
What happened
Now this is a stock pop. On Thursday, shares of Lexicon Pharmaceutials(NASDAQ:LXRX) jumped 105% (no, that’s not a typo) after the company issued a major positive regulatory update.
So what
The happy news is that Lexicon’s clinical-stage protein inhibitor sotagliflozin performed well enough in phase 3 clinical trials to support a New Drug Application (NDA) from the Food and Drug Administration. This paves the way for sotagliflozin to win approval for treating patients at risk of heart…
-
Noosa News24 hours agoThis 42-Kilometre Walking Trail on the NSW North Coast Weaves Through Ancient Rainforest, Volcanic Mountains and Spectacular Waterfalls
-
Noosa News22 hours agoQueensland cop cleared by court of stealing watches during anti-gang raid
-
Noosa News22 hours agoEaster weather forecast: What to expect in Sydney, Perth, Melbourne, Brisbane, Adelaide and Canberra
-
Noosa News23 hours agoAnother power station confirmed offline as political fallout continues amid cultural issues